Level Four Advisory Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396K | Sell |
7,173
-1,053
| -13% | -$57.1K | 0.01% | 643 |
|
|
2025
Q4 | $403K | Buy |
8,226
+354
| +4% | +$16.5K | 0.01% | 616 |
|
|
2025
Q3 | $340K | Sell |
7,872
-1,256
| -14% | -$49.1K | 0.01% | 644 |
|
|
2025
Q2 | $351K | Buy |
9,128
+255
| +3% | +$9.74K | 0.01% | 617 |
|
|
2025
Q1 | $344K | Sell |
8,873
-279
| -3% | -$10.2K | 0.01% | 590 |
|
|
2024
Q4 | $310K | Buy |
9,152
+511
| +6% | +$18.4K | 0.01% | 616 |
|
|
2024
Q3 | $318K | Buy |
8,641
+1,621
| +23% | +$66.3K | 0.01% | 619 |
|
|
2024
Q2 | $270K | Sell |
7,020
-7,458
| -52% | -$314K | 0.01% | 638 |
|
|
2024
Q1 | $537K | Hold |
14,478
| – | – | 0.03% | 448 |
|
|
2023
Q4 | $537K | Sell |
14,478
-1,384
| -9% | -$49.7K | 0.03% | 445 |
|
|
2023
Q3 | $575K | Sell |
15,862
-1,240
| -7% | -$44K | 0.04% | 408 |
|
|
2023
Q2 | $610K | Sell |
17,102
-2,022
| -11% | -$72.5K | 0.04% | 416 |
|
|
2023
Q1 | $680K | Sell |
19,124
-6,172
| -24% | -$216K | 0.04% | 355 |
|
|
2022
Q4 | $889K | Buy |
25,296
+11,121
| +78% | +$370K | 0.07% | 273 |
|
|
2022
Q3 | $417K | Sell |
14,175
-321
| -2% | -$12.2K | 0.04% | 349 |
|
|
2022
Q2 | $789K | Buy |
14,496
+395
| +3% | +$21.8K | 0.07% | 260 |
|
|
2022
Q1 | $768K | Sell |
14,101
-4,372
| -24% | -$237K | 0.06% | 294 |
|
|
2021
Q4 | $1.02M | Buy |
18,473
+4,406
| +31% | +$229K | 0.08% | 247 |
|
|
2021
Q3 | $672K | Sell |
14,067
-765
| -5% | -$38.4K | 0.07% | 247 |
|
|
2021
Q2 | $738K | Sell |
14,832
-250
| -2% | -$12K | 0.05% | 323 |
|
|
2021
Q1 | $673K | Buy |
15,082
+4,347
| +40% | +$197K | 0.05% | 328 |
|
|
2020
Q4 | $494K | Sell |
10,735
-383
| -3% | -$17.6K | 0.04% | 369 |
|
|
2020
Q3 | $523K | Sell |
11,118
-1,260
| -10% | -$63.1K | 0.04% | 342 |
|
|
2020
Q2 | $626K | Buy |
12,378
+405
| +3% | +$20.8K | 0.05% | 328 |
|
|
2020
Q1 | $570K | Sell |
11,973
-5,731
| -32% | -$306K | 0.07% | 296 |
|
|
2019
Q4 | $1.15M | Buy |
17,704
+2,120
| +14% | +$118K | 0.05% | 260 |
|
|
2019
Q3 | $832K | Buy |
15,584
+214
| +1% | +$11K | 0.09% | 233 |
|
|
2019
Q2 | $769K | Sell |
15,370
-252
| -2% | -$12.6K | 0.08% | 242 |
|
|
2019
Q1 | $816K | Buy |
15,622
+5,317
| +52% | +$266K | 0.09% | 225 |
|
|
2018
Q4 | $492K | Buy |
10,305
+538
| +6% | +$26.5K | 0.06% | 297 |
|
|
2018
Q3 | $490K | Sell |
9,767
-2,983
| -23% | -$152K | 0.05% | 346 |
|
|
2018
Q2 | $642K | Buy |
12,750
+283
| +2% | +$14.3K | 0.05% | 330 |
|
|
2018
Q1 | $609K | Buy |
12,467
+2,789
| +29% | +$130K | 0.05% | 332 |
|
|
2017
Q4 | $429K | Sell |
9,678
-12,699
| -57% | -$587K | 0.03% | 389 |
|
|
2017
Q3 | $1.14M | Buy |
22,377
+7,783
| +53% | +$395K | 0.1% | 192 |
|
|
2017
Q2 | $765K | Sell |
14,594
-2,684
| -16% | -$143K | 0.12% | 187 |
|
|
2017
Q1 | $906K | Sell |
17,278
-722
| -4% | -$36.6K | 0.09% | 217 |
|
|
2016
Q4 | $866K | Buy |
+18,000
| New | +$889K | 0.11% | 191 |
|
Other funds holding GSK
JEST
Level Four Advisory Services's GSK Position: Q1 2026 in Review
Level Four Advisory Services reduced its GSK (GSK) stake by 13% in Q1 2026, selling an estimated $57.1K and leaving 7,173 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #643.
Level Four Advisory Services first reported a position in GSK in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.15M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Level Four Advisory Services held 7,173 shares of GSK worth $396K as of Q1 2026.
- Level Four Advisory Services sold 1,053 GSK shares in Q1 2026, an estimated $57.1K.
- GSK made up 0.01% of Level Four Advisory Services's portfolio in Q1 2026, its #643 holding.
- Level Four Advisory Services first reported a position in GSK in Q4 2016 and has held it in 38 quarters since.
- Level Four Advisory Services's GSK position peaked at $1.15M in Q4 2019.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.